Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2198-9788

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™) ; day:26 ; month:5 ; year:2021 ; pages:1-10
Drugs - real world outcomes ; (26.5.2021), 1-10

Creator: Sims, Charles R.
Bressler, Adam M.
Graham, Donald R.
Lacy, Melinda K.
Lombardi, David A.
Castaneda-Ruiz, Bibiana

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40801-021-00255-6

URN: urn:nbn:de:101:1-2021092222184127775283

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Sims, Charles R.
Bressler, Adam M.
Graham, Donald R.
Lacy, Melinda K.
Lombardi, David A.
Castaneda-Ruiz, Bibiana
SpringerLink (Online service)

Other Objects (12)

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

In the Real-World, Kids Use Medications and Devices

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

Hemopatch® is effective and safe to use: real-world data from a prospective European registry study

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

Tigecycline use in serious nosocomial infections: a drug use evaluation

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

In the Real-World, Kids Use Medications and Devices

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

Hemopatch® is effective and safe to use: real-world data from a prospective European registry study

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

Tigecycline use in serious nosocomial infections: a drug use evaluation

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

In the Real-World, Kids Use Medications and Devices

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

Hemopatch® is effective and safe to use: real-world data from a prospective European registry study

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

Tigecycline use in serious nosocomial infections: a drug use evaluation

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

In the Real-World, Kids Use Medications and Devices

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

Hemopatch® is effective and safe to use: real-world data from a prospective European registry study

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

Tigecycline use in serious nosocomial infections: a drug use evaluation

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

In the Real-World, Kids Use Medications and Devices

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

Hemopatch® is effective and safe to use: real-world data from a prospective European registry study

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

Tigecycline use in serious nosocomial infections: a drug use evaluation

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

In the Real-World, Kids Use Medications and Devices

Real-World Use of Oritavancin for the Treatment of Osteomyelitis

Hemopatch® is effective and safe to use: real-world data from a prospective European registry study

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

Tigecycline use in serious nosocomial infections: a drug use evaluation

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

Related objects

Reset password